Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10963106 | Vaccine | 2015 | 5 Pages |
Abstract
Persistent T cell activation following immunization with HIV vaccines may increase HIV acquisition risk. We investigated the magnitude and kinetics of T cell activation following vaccination of rhesus macaques with a candidate HIV vaccine consisting of a recombinant DNA and MVA vaccination regimen. We show that global CD4+ and CD8+ T cell activation, as measured by the expression of Ki67 and Bcl-2, peaked one week after boosting with MVA, but then waned rapidly to pre-vaccination levels. Furthermore, increased frequencies of CD4+ CCR5+ T cells, which represent potential HIV target cells, were short-lived and decreased to baseline levels within two months. Activated CD4+ T cells were predominantly of a central memory phenotype, and activated CD8+ T cells were distributed between central and effector memory phenotypes. Thus, only transient changes in T cell activation occurred following poxvirus vaccination, indicating a lack of persistent immune activation.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Andreia Soares, Tracey L. Müller, Gerald K. Chege, Anna-Lise Williamson, Wendy A. Burgers,